Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Eye Research Foundation, Inc.24 enrolled

Overview

A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Blepharitis

Interventions

Moxidectin 2 MG Oral TabletDRUG

active medication

PlaceboDRUG

placebo pills

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Active blepharitis with collarettes Exclusion Criteria: * Other clinically significant eye disease

Locations (1)

Eye Research Foundation, Inc.

Newport Beach, California, United States

Outcomes

Primary Outcomes

Collarette count

Collarette Count

Time frame: 6 weels

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.